Systemic Sclerosis (SSc)
90
47
49
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
1.1%
1 terminated out of 90 trials
85.7%
-0.9% vs benchmark
4%
4 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (90)
A Phase 1b Study of C-CAR168 in Participants With Systemic Sclerosis (SSc)
Home-based Exercise for Improving Health-related Quality of Life in Systemic Sclerosis
Combined Growth Differentiation Factor-15 (GDF-15) and Lung Ultrasound for ILD Screening in Rheumatoid Arthritis and Systemic Sclerosis
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
Investigation of Type I Interferon Excess in Patients With Systemic Autoimmune Diseases and Genetic Type I Interferonopathies
Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined With Immunosuppressants in the Treatment of Refractory Autoimmune Diseases
Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases
Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
A Study of ATG-201 in Adult Participants With Autoimmune Diseases
Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis
A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.
Nebulized UC-EVs for Recurrent or Refractory IMIDs With Lung Involvement
FT839 in Autoimmune Diseases
Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases
Mass Spectrometry-based Immune Profiling in Autoimmune Diseases
Controlling Hyperactive Immunity With Long-lived Lymphocytes
Efficacy of A Non-Invasive Botulinum Toxin Microneedle Pad for the Treatment of Secondary Raynaud's Phenomenon
DERMATOMICS: Identifying Regulators of Skin Homeostasis
TENS in Scleroderma
Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases